Cargando…
Immunotherapies of retinoblastoma: Effective methods for preserving vision in the future
Retinoblastoma is the most common intraocular tumor in children. Patients can be cured by enucleation, but it can lead to vision loss. Chemotherapy is the main method of treatment for RB currently. Unfortunately, chemoresistant and tumor metastasis often happen, resulting in a relatively poor progno...
Autores principales: | Wang, Ling, Li, Shixu, Mei, Jun, Ye, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483150/ https://www.ncbi.nlm.nih.gov/pubmed/36132125 http://dx.doi.org/10.3389/fonc.2022.949193 |
Ejemplares similares
-
Treatment of Retinoblastoma: What Is the Latest and What Is the Future
por: Schaiquevich, Paula, et al.
Publicado: (2022) -
Retinoblastoma and vision
por: Warda, Omar, et al.
Publicado: (2022) -
Retinoblastoma: Review and new insights
por: Cruz-Gálvez, Claudia Carolina, et al.
Publicado: (2022) -
Future vision for the quality assurance of oncology clinical trials
por: FitzGerald, Thomas J., et al.
Publicado: (2013) -
Past, Current, and Future of Immunotherapies for Prostate Cancer
por: Boettcher, Adeline N., et al.
Publicado: (2019)